Zhitong Finance App News, ST Renfu (600079.SH) announced that the company's holding subsidiary, Yichang Renfu Pharmaceutical Co., Ltd. (“Yichang Renfu”, the company holds 80% of its shares) recently received the “Drug Clinical Trial Approval Notice” for midazolam nasal spray approved and issued by the State Drug Administration.

Zhitongcaijing · 2d ago
Zhitong Finance App News, ST Renfu (600079.SH) announced that the company's holding subsidiary, Yichang Renfu Pharmaceutical Co., Ltd. (“Yichang Renfu”, the company holds 80% of its shares) recently received the “Drug Clinical Trial Approval Notice” for midazolam nasal spray approved and issued by the State Drug Administration.